Yes I do agree data will help provide evidence or proof to mitigate risk, but is this enough?
It has been discussed things need to occur for Benitec's success:
Science (preclinical looked brilliant)
Funds (check, albeit not a huge sum but approx $40m so far raised)
NASDAQ listing (check)
Yet the stock still looks no better off. So what is missing? Is data really the linchpin?
BLT Price at posting:
60.0¢ Sentiment: Buy Disclosure: Held